Epsilon toxin: A fascinating pore-forming toxin

FEBS Journal

Volumn 278, Issue 23, 2011, Pages 4602-4615

  Popoff, Michel R ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

aerolysin; Clostridium perfringens; Clostridium septicum alpha toxin; enterotoxemia; epsilon toxin; glutamate; lipid bilayer; necrosis; pore; pore forming toxin

Indexed keywords

BACTERIAL TOXIN; BACTERIAL VACCINE; EPSILON TOXIN; GLUTAMIC ACID; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

AMINO ACID SYNTHESIS; BACTERIAL GENETICS; BINDING SITE; BRAIN DISEASE; CHANNEL GATING; CLOSTRIDIUM PERFRINGENS; ENTEROTOXEMIA; HUMAN; INFECTION PREVENTION; INTESTINE ABSORPTION; INTESTINE BLOOD FLOW; INTESTINE OBSTRUCTION; KIDNEY DISEASE; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; TOXIN ANALYSIS; TOXIN STRUCTURE; TOXIN SYNTHESIS; VACCINATION;

ANIMALS; BACTERIAL TOXINS; BLOOD-BRAIN BARRIER; BRAIN; CELL DEATH; CLOSTRIDIUM PERFRINGENS; ENTEROTOXEMIA; HUMANS; KIDNEY; NECROSIS;

ANIMALIA; CLOSTRIDIUM; CLOSTRIDIUM PERFRINGENS; CLOSTRIDIUM SEPTICUM; EUKARYOTA; OVIS ARIES;

EID: 81555195262     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2011.08145.x     Document Type: Review

References (106)

1. Petit L, Gibert M, &, Popoff MR, (1999) Clostridium perfringens: toxinotype and genotype. Trends Microbiol 7, 104-110. (Pubitemid 29271996)
2. Gill DM, (1987) Bacterial toxins: lethal amounts. In Toxins and Enzymes (, Laskin AI, &, Lechevalier HA, eds), pp. 127-135. CRC Press, Cleveland.
3. Minami J, Katayama S, Matsushita O, Matsushita C, &, Okabe A, (1997) Lambda-toxin of Clostridium perfringens activates the precursor of epsilon-toxin by releasing its N- and C-terminal peptides. Microbiol Immunol 41, 527-535. (Pubitemid 27318089)
4. Mantis NJ, (2005) Vaccines against the category B toxins: staphylococcal enterotoxin B, epsilon toxin and ricin. Adv Drug Deliv Rev 57, 1424-1439. (Pubitemid 40791120)
5. Knapp O, Stiles BG, &, Popoff MR, (2010) The aerolysin-like toxin family of cytolytic, pore-forming toxins. Open Toxicol J 3, 53-68.
6. Bullen JJ, (1952) Enterotoxaemia of sheep: Clostridium welchii type D in the alimentary tract of normal animals. J Pathol Bacteriol 64, 201-206.
7. Bullen JJ, &, Battey I, (1957) Enterotoxaemia of sheep. Vet Rec 69, 1268-1273.
8. Finnie JW, (2004) Neurological disorders produced by Clostridium perfringens type D epsilon toxin. Anaerobe 10, 145-150. (Pubitemid 38519815)
9. Uzal FA, (2004) Diagnosis of Clostridium perfringens intestinal infections in sheep and goats. Anaerobe 10, 135-143. (Pubitemid 38519814)
10. Uzal FA, &, Kelly WR, (1998) Experimental Clostridium perfringens type D enterotoxemia in goats. Vet Pathol 35, 132-140. (Pubitemid 129543201)
11. Gardner DE, (1973) Pathology of Clostridium welchii type D enterotoxaemia. II. Structural and ultrastructural alterations in the tissues of lambs and mice. J Comp Pathol 83, 509-524.
12. Gardner DE, (1973) Pathology of Clostridium welchii type D enterotoxaemia. I. Biochemical and haematological alterations in lambs. J Comp Pathol 83, 499-507.
13. Filho EJ, Carvalho AU, Assis RA, Lobato FF, Rachid MA, Carvalho AA, Ferreira PM, Nascimento RA, Fernandes AA, Vidal JE, et al. (2009) Clinicopathologic features of experimental Clostridium perfringens type D enterotoxemia in cattle. Vet Pathol 46, 1213-1220.
14. Uzal FA, &, Kelly WR, (1996) Enterotoxaemia in goats. Vet Res Commun 20, 481-492. (Pubitemid 126707123)
15. Uzal FA, &, Songer JG, (2008) Diagnosis of Clostridium perfringens intestinal infections in sheep and goats. J Vet Diagn Invest 20, 253-265. (Pubitemid 352844373)
16. Shortt SJ, Titball RW, &, Lindsay CD, (2000) An assessment of the in vitro toxicology of Clostridium perfringens type D epsilon-toxin in human and animal cells. Hum Exp Toxicol 19, 108-116. (Pubitemid 30189872)
17. Fernandez Miyakawa ME, Zabal O, &, Silberstein C, (2011) Clostridium perfringens epsilon toxin is cytotoxic for human renal tubular epithelial cells. Hum Exp Toxicol 30, 275-282.
18. Gleeson-White MH, &, Bullen JJ, (1955) Clostridium welchii epsilon toxin in the intestinal contents of man. Lancet 268, 384-385.
19. Kohn J, &, Warrack GH, (1955) Recovery of Clostridium welchii type D from man. Lancet 268, 385.
20. Myers GS, Rasko DA, Cheung JK, Ravel J, Seshadri R, DeBoy RT, Ren Q, Varga J, Awad MM, Brinkac LM, et al. (2006) Skewed genomic variability in strains of the toxigenic bacterial pathogen, Clostridium perfringens. Genome Res 16, 1031-1040. (Pubitemid 44162262)
21. Hughes ML, Poon R, Adams V, Sayeed S, Saputo J, Uzal FA, McClane BA, &, Rood JI, (2007) Epsilon-toxin plasmids of Clostridium perfringens type D are conjugative. J Bacteriol 189, 7531-7538. (Pubitemid 350035061)
22. Sayeed S, Li J, &, McClane BA, (2007) Virulence plasmid diversity in Clostridium perfringens type D isolates. Infect Immun 75, 2391-2398. (Pubitemid 46744329)
23. Sayeed S, Li J, &, McClane BA, (2010) Characterization of virulence plasmid diversity among Clostridium perfringens type B isolates. Infect Immun 78, 495-504.
24. Deguchi A, Miyamoto K, Kuwahara T, Miki Y, Kaneko I, Li J, McClane BA, &, Akimoto S, (2009) Genetic characterization of type A enterotoxigenic Clostridium perfringens strains. PLoS ONE 4, e5598.
25. Kobayashi S, Wada A, Shibasaki S, Annaka M, Higuchi H, Adachi K, Mori N, Ishikawa T, Masuda Y, Watanabe H, et al. (2009) Spread of a large plasmid carrying the cpe gene and the tcp locus amongst Clostridium perfringens isolates from nosocomial outbreaks and sporadic cases of gastroenteritis in a geriatric hospital. Epidemiol Infect 137, 108-113.
26. Miyamoto K, Li J, Sayeed S, Akimoto S, &, McClane BA, (2008) Sequencing and diversity analyses reveal extensive similarities between some epsilon-toxin-encoding plasmids and the pCPF5603 Clostridium perfringens enterotoxin plasmid. J Bacteriol 190, 7178-7188.
27. Hunter SE, Clarke IN, Kelly DC, &, Titball RW, (1992) Cloning and nucleotide sequencing of the Clostridium perfringens epsilon-toxin gene and its expression in Escherichia coli. Infect Immun 60, 102-110.
28. Bullen JJ, &, Batty I, (1957) Experimental enterotoxaemia of sheep: the effect on the permeability of the intestine and the stimulation of antitoxin production in immune animals. J Pathol Bacteriol 73, 511-518.
29. Bullen JJ, &, Scarisbrick R, (1957) Enterotoxaemia of sheep: experimental reproduction of the disease. J Pathol Bacteriol 73, 495-509.
30. Fernandez Miyakawa ME, Ibarra CA, &, Uzal FA, (2003) In vitro effects of Clostridium perfringens type D epsilon toxin on water and ion transport in ovine and caprine intestine. Anaerobe 9, 145-149. (Pubitemid 36970213)
31. Fernandez Miyakawa ME, &, Uzal FA, (2003) The early effects of Clostridium perfringens type D epsilon toxin in ligated intestinal loops of goats and sheep. Vet Res Commun 27, 231-241. (Pubitemid 36582642)
32. Fernandez-Miyakawa ME, Jost BH, Billington SJ, &, Uzal FA, (2008) Lethal effects of Clostridium perfringens epsilon toxin are potentiated by alpha and perfringolysin-O toxins in a mouse model. Vet Microbiol 127, 379-385. (Pubitemid 351173522)
33. Goldstein J, Morris WE, Loidl CF, Tironi-Farinatti C, McClane BA, Uzal FA, &, Fernandez Miyakawa ME, (2009) Clostridium perfringens epsilon toxin increases the small intestinal permeability in mice and rats. PLoS ONE 4, e7065.
34. Batty I, &, Bullen JJ, (1956) The effect of Clostridium welchii type D culture filtrates on the permeability of the mouse intestine. J Pathol Bacteriol 71, 311-323.
35. Losada-Eaton DM, Uzal FA, &, Fernandez Miyakawa ME, (2008) Clostridium perfringens epsilon toxin is absorbed from different intestinal segments of mice. Toxicon 51, 1207-1213.
36. Sakurai J, Nagahama M, &, Takahashi T, (1989) Contraction induced by Clostridium perfringens epsilon toxin in the isolated rat ileum. FEMS Microbiol Lett 49, 269-272. (Pubitemid 19087815)
37. Losada-Eaton DM, &, Fernandez-Miyakawa ME, (2010) Clostridium perfringens epsilon toxin inhibits the gastrointestinal transit in mice. Res Vet Sci 89, 404-408.
38. Adamson RH, Ly JC, Fernandez-Miyakawa M, Ochi S, Sakurai J, Uzal F, &, Curry FE, (2005) Clostridium perfringens epsilon-toxin increases permeability of single perfused microvessels of rat mesentery. Infect Immun 73, 4879-4887. (Pubitemid 41105644)
39. Buxton D, (1978) Further studies on the mode of action of Clostridium welchii type-D epsilon toxin. J Med Microbiol 11, 293-298. (Pubitemid 9001180)
40. Soler-Jover A, Blasi J, Gomez de Aranda I, Navarro P, Gibert M, Popoff MR, &, Martin-Satue M, (2004) Effect of epsilon toxin-GFP on MDCK cells and renal tubules in vivo. J Histochem Cytochem 52, 931-942. (Pubitemid 38857158)
41. Uzal FA, Rolfe BE, Smith NJ, Thomas AC, &, Kelly WR, (1999) Resistance of ovine, caprine and bovine endothelial cells to Clostridium perfringens type D epsilon toxin in vitro. Vet Res Commun 23, 275-284. (Pubitemid 129577285)
42. Nagahama M, Iida H, &, Sakurai J, (1993) Effect of Clostridium perfringens epsilon toxin on rat isolated aorta. Microbiol Immunol 37, 447-450. (Pubitemid 23245489)
43. Sakurai J, Nagahama M, &, Fujii Y, (1983) Effect of Clostridium perfringens epsilon toxin on the cardiovascular system of rats. Infect Immun 42, 1183-1186. (Pubitemid 14244393)
44. Tamai E, Ishida T, Miyata S, Matsushita O, Suda H, Kobayashi S, Sonobe H, &, Okabe A, (2003) Accumulation of Clostridium perfringens epsilon-toxin in the mouse kidney and its possible biological significance. Infect Immun 71, 5371-5375. (Pubitemid 37070786)
45. Chassin C, Bens M, de Barry J, Courjaret R, Bossu JL, Cluzeaud F, Ben Mkaddem S, Gibert M, Poulain B, Popoff MR, et al. (2007) Pore-forming epsilon toxin causes membrane permeabilization and rapid ATP depletion-mediated cell death in renal collecting duct cells. Am J Physiol Renal Physiol 293, F927-F937. (Pubitemid 47403365)
46. Lindsay CD, Hambrook JL, &, Upshall DG, (1995) Examination of toxicity of Clostridium perfringensε-toxin in the MDCK cell line. Toxic In Vitro 9, 213-218.
47. Payne DW, Williamson ED, Havard H, Modi N, &, Brown J, (1994) Evaluation of a new cytotoxicity assay for Clostridium perfringens type D epsilon toxin. FEMS Microbiol Lett 116, 161-168. (Pubitemid 24069292)
48. Gardner DE, (1973) Pathology of Clostridium welchii type D enterotoxaemia. 3. Basis of the hyperglycaemic response. J Comp Pathol 83, 525-529.
49. Nagahama M, &, Sakurai J, (1991) Distribution of labeled Clostridium perfringens epsilon toxin in mice. Toxicon 29, 211-217.
50. Nagahama M, &, Sakurai J, (1992) High-affinity binding of Clostridium perfringens epsilon-toxin to rat brain. Infect Immun 60, 1237-1240.
51. Finnie JW, &, Hajduk P, (1992) An immunohistochemical study of plasma albumin extravasation in the brain of mice after the administration of Clostridium perfringens type D epsilon toxin. Aust Vet J 69, 261-262.
52. Griner LA, &, Carlson WD, (1961) Enterotoxemia of sheep. II. Distribution of 131I-radioiodinated serum albumin in brain of Clostridium perfringens type D intoxicated lambs. Am J Vet Res 22, 443-446.
53. Worthington RW, &, Mulders MS, (1975) Effect of Clostridium perfringens epsilon toxin on the blood-brain barrier of mice. Onderstepoort J Vet Res 42, 25-27.
54. Zhu C, Ghabriel MN, Blumbergs PC, Reilly PL, Manavis J, Youssef J, Hatami S, &, Finnie JW, (2001) Clostridium perfringens prototoxin-induced alteration of endothelial barrier antigen (EBA) immunoreactivity at the blood-brain barrier (BBB). Exp Neurol 169, 72-82. (Pubitemid 32424324)
55. Morgan KT, Kelly BG, &, Buxton D, (1975) Vascular leakage produced in the brains of mice by Clostridium welchii type D toxin. J Comp Pathol 85, 461-466.
56. Finnie JW, Blumbergs PC, &, Manavis J, (1999) Neuronal damage produced in rat brains by Clostridium perfringens type D epsilon toxin. J Comp Pathol 120, 415-420. (Pubitemid 29204494)
57. Finnie JW, (1984) Ultrastructural changes in the brain of mice given Clostridium perfringens type D epsilon toxin. J Comp Pathol 94, 445-452. (Pubitemid 15070112)
58. Finnie JW, (2003) Pathogenesis of brain damage produced in sheep by Clostridium perfringens type D epsilon toxin: a review. Aust Vet J 81, 219-221. (Pubitemid 43934479)
59. Morgan KT, &, Kelly BG, (1974) Ultrastructural study of brain lesions produced in mice by the administration of Clostridium welchii type D toxin. J Comp Pathol 84, 181-191.
60. Finnie JW, (1984) Histopathological changes in the brain of mice given Clostridium perfringens type D epsilon toxin. J Comp Pathol 94, 363-370. (Pubitemid 15070105)
61. Ghabriel MN, Zhu C, Reilly PL, Blumbergs PC, Manavis J, &, Finnie JW, (2000) Toxin-induced vasogenic cerebral oedema in a rat model. Acta Neurochir Suppl 76, 231-236.
62. Finnie JW, Manavis J, &, Blumbergs PC, (2008) Aquaporin-4 in acute cerebral edema produced by Clostridium perfringens type D epsilon toxin. Vet Pathol 45, 307-309.
63. Baldwin EM Jr, &, Griner LA, (1956) Clostridia in diarrheal diseases of animals. Ann NY Acad Sci 66, 168-175.
64. Buxton D, (1978) The use of an immunoperoxidase technique to investigate by light and electron microscopy the sites of binding of Clostridium welchii type-D epsilon toxin in mice. J Med Microbiol 11, 289-292. (Pubitemid 9001179)
65. Uzal FA, Kelly WR, Morris WE, Bermudez J, &, Baison M, (2004) The pathology of peracute experimental Clostridium perfringens type D enterotoxemia in sheep. J Vet Diagn Invest 16, 403-411. (Pubitemid 39250947)
66. Uzal FA, Kelly WR, Morris WE, &, Assis RA, (2002) Effects of intravenous injection of Clostridium perfringens type D epsilon toxin in calves. J Comp Pathol 126, 71-75.
67. Soler-Jover A, Dorca J, Popoff MR, Gibert M, Saura J, Tusell JM, Serratosa J, Blasi J, &, Martin-Satue M, (2007) Distribution of Clostridium perfringens epsilon toxin in the brains of acutely intoxicated mice and its effect upon glial cells. Toxicon 50, 530-540. (Pubitemid 47368587)
68. Lonchamp E, Dupont JL, Wioland L, Courjaret R, Mbebi-Liegeois C, Jover E, Doussau F, Popoff MR, Bossu JL, de Barry J, et al. (2011) Clostridium perfringens epsilon toxin targets granule cells in the mouse cerebellum and stimulates glutamate release. PLoS ONE 5, e13046.
69. Dorca-Arevalo J, Soler-Jover A, Gibert M, Popoff MR, Martin-Satue M, &, Blasi J, (2008) Binding of epsilon-toxin from Clostridium perfringens in the nervous system. Vet Microbiol 131, 14-25.
70. Miyamoto O, Minami J, Toyoshima T, Nakamura T, Masada T, Nagao S, Negi T, Itano T, &, Okabe A, (1998) Neurotoxicity of Clostridium perfringens epsilon-toxin for the rat hipocampus via glutamanergic system. Infect Immun 66, 2501-2508. (Pubitemid 28261744)
71. Miyamoto O, Sumitami K, Nakamura T, Yamagani S, Miyatal S, Itano T, Negi T, &, Okabe A, (2000) Clostridium perfringens epsilon toxin causes excessive release of glutamate in the mouse hippocampus. FEMS Microbiol Lett 189, 109-113. (Pubitemid 30456256)
72. Nagahama M, &, Sakurai J, (1993) Effect of drugs acting on the central nervous system on the lethality in mice of Clostridium perfringens epsilon toxin. Toxicon 31, 427-435.
73. Phannachet K, Raksat P, Limvuttegrijeerat T, &, Promdonkoy B, (2011) Production and characterization of N- and C-terminally truncated Mtx2: a mosquitocidal toxin from Bacillus sphaericus. Curr Microbiol 61, 549-553.
74. Sakaguchi Y, Hayashi T, Yamamoto Y, Nakayama K, Zhang K, Ma S, Arimitsu H, &, Oguma K, (2009) Molecular analysis of an extrachromosomal element containing the C2 toxin gene discovered in Clostridium botulinum type C. J Bacteriol 191, 3282-3291.
75. Cole A, (2003) Structural studies on epsilon toxin from Clostridium perfringens. In Protein Toxins of the Genus Clostridium and Vaccination (, Duchesnes C, Mainil J, Popoff MR, &, Titball R, eds), p. 95. Presses de la Faculté de Médecine Vétérinaire, Liège.
76. Gurcel L, Iacovache I, &, van der Goot FG, (2006) Aerolysin and related Aeromonas toxins. In The Source Book of Bacterial Protein Toxins (, Alouf JE, &, Popoff MR, eds), pp. 606-620. Elsevier, Amsterdam.
77. Parker MW, Buckley JT, Postma JP, Tucker AD, Leonard K, Pattus F, &, Tsernoglou D, (1994) Structure of the Aeromonas toxin proaerolysin in its water-soluble and membrane-channel states. Nature 367, 292-295. (Pubitemid 24051148)
78. Melton JA, Parker MW, Rossjohn J, Buckley JT, &, Tweten RK, (2004) The identification and structure of the membrane-spanning domain of the Clostridium septicum alpha toxin. J Biol Chem 279, 14315-14322. (Pubitemid 38468972)
79. Tweten RK, (2001) Clostridium perfringens beta toxin and Clostridium septicum alpha toxin: their mechanisms and possible role in pathogenesis. Vet Microbiol 82, 1-9. (Pubitemid 32553813)
80. Knapp O, Maier E, Benz R, Geny B, &, Popoff MR, (2009) Identification of the channel-forming domain of Clostridium perfringens epsilon-toxin (ETX). Biochim Biophys Acta 1788, 2584-2593.
81. Geny B, &, Popoff MR, (2006) Bacterial protein toxins and lipids: pore formation or toxin entry into cells. Biol Cell 98, 667-678. (Pubitemid 44697058)
82. Schleberger C, Hochmann H, Barth H, Aktories K, &, Schulz GE, (2006) Structure and action of the binary C2 toxin from Clostridium botulinum. J Mol Biol 364, 705-715. (Pubitemid 44755316)
83. Sakurai J, (1995) Toxins of Clostridium perfringens. Rev Med Microbiol 6, 175-185.
84. Oyston PCF, Payne DW, Havard HL, Williamson ED, &, Titball RW, (1998) Production of a non-toxic site-directed mutant of Clostridium perfringensε-toxin which induces protective immunity in mice. Microbiology 144, 333-341. (Pubitemid 28067738)
85. Heine K, Pust S, Enzenmuller S, &, Barth H, (2008) ADP-ribosylation of actin by the Clostridium botulinum C2 toxin in mammalian cells results in delayed caspase-dependent apoptotic cell death. Infect Immun 76, 4600-4608.
86. Petit L, Gibert M, Gillet D, Laurent-Winter C, Boquet P, &, Popoff MR, (1997) Clostridium perfringens epsilon-toxin acts on MDCK cells by forming a large membrane complex. J Bacteriol 179, 6480-6487. (Pubitemid 27443933)
87. Borrmann E, Günther H, &, Köhler H, (2001) Effect of Clostridium perfringens epsilon toxin on MDCK cells. FEMS Immunol Med Microbiol 31, 85-92. (Pubitemid 32822871)
88. Miyata S, Matsushita O, Minami J, Katayama S, Shimamoto S, &, Okabe A, (2001) Cleavage of C-terminal peptide is essential for heptamerization of Clostridium perfringens epsilon-toxin in the synaptosomal membrane. J Biol Chem 276, 13778-13783.
89. Miyata S, Minami J, Tamai E, Matsushita O, Shimamoto S, &, Okabe A, (2002) Clostridium perfringens epsilon-toxin forms a heptameric pore within the detergent-insoluble microdomains of Madin-Darby canine kidney cells and rat synaptosomes. J Biol Chem 277, 39463-39468. (Pubitemid 35190922)
90. Payne D, Williamson ED, &, Titball RW, (1997) The Clostridium perfringens epsilon-toxin. Rev Med Microbiol 8, S28-S30.
91. Ivie SE, Fennessey CM, Sheng J, Rubin DH, &, McClain MS, (2011) Gene-trap mutagenesis identifies mammalian genes contributing to intoxication by Clostridium perfringens epsilon-toxin. PLoS ONE 6, e17787.
92. Petit L, Maier E, Gibert M, Popoff MR, &, Benz R, (2001) Clostridium perfringens epsilon-toxin induces a rapid change in cell membrane permeability to ions and forms channels in artificial lipid bilayers. J Biol Chem 276, 15736-15740.
93. Shimamoto S, Tamai E, Matsushita O, Minami J, Okabe A, &, Miyata S, (2005) Changes in ganglioside content affect the binding of Clostridium perfringens epsilon-toxin to detergent-resistant membranes of Madin-Darby canine kidney cells. Microbiol Immunol 49, 245-253.
94. Nagahama M, Hara H, Fernandez-Miyakawa M, Itohayashi Y, &, Sakurai J, (2006) Oligomerization of Clostridium perfringens epsilon-toxin is dependent upon membrane fluidity in liposomes. Biochemistry 45, 296-302. (Pubitemid 43054107)
95. Masson JB, Casanova D, Turkcan S, Voisinne G, Popoff MR, Vergassola M, &, Alexandrou A, (2009) Inferring maps of forces inside cell membrane microdomains. Phys Rev Lett 102, 048103-1-4.
96. Nestorovich EM, Karginov VA, &, Bezrukov SM, (2011) Polymer partitioning and ion selectivity suggest asymmetrical shape for the membrane pore formed by epsilon toxin. Biophys J 99, 782-789.
97. Petit L, Gibert M, Gourch A, Bens M, Vandewalle A, &, Popoff MR, (2003) Clostridium perfringens epsilon toxin rapidly decreases membrane barrier permeability of polarized MDCK cells. Cell Microbiol 5, 155-164. (Pubitemid 36348032)
98. Knapp O, Maier E, Mkaddem SB, Benz R, Bens M, Chenal A, Geny B, Vandewalle A, &, Popoff MR, (2010) Clostridium septicum alpha-toxin forms pores and induces rapid cell necrosis. Toxicon 55, 61-72.
99. Titball RW, (2009) Clostridium perfringens vaccines. Vaccine 27 (Suppl 4), D44-D47.
100. Lobato FC, Lima CG, Assis RA, Pires PS, Silva RO, Salvarani FM, Carmo AO, Contigli C, &, Kalapothakis E, (2010) Potency against enterotoxemia of a recombinant Clostridium perfringens type D epsilon toxoid in ruminants. Vaccine 28, 6125-6127.
101. Mathur DD, Deshmukh S, Kaushik H, &, Garg LC, (2010) Functional and structural characterization of soluble recombinant epsilon toxin of Clostridium perfringens D, causative agent of enterotoxaemia. Appl Microbiol Biotechnol 88, 877-884.
102. Souza AM, Reis JK, Assis RA, Horta CC, Siqueira FF, Facchin S, Alvarenga ER, Castro CS, Salvarani FM, Silva RO, et al. (2010) Molecular cloning and expression of epsilon toxin from Clostridium perfringens type D and tests of animal immunization. Genet Mol Res 9, 266-276.
103. Pelish TM, &, McClain MS, (2009) Dominant-negative inhibitors of the Clostridium perfringens epsilon-toxin. J Biol Chem 284, 29446-29453.
104. McClain MS, &, Cover TL, (2007) Functional analysis of neutralizing antibodies against Clostridium perfringens epsilon-toxin. Infect Immun 75, 1785-1793. (Pubitemid 46559446)
105. Lewis M, Weaver CD, &, McClain MS, (2011) Identification of small molecule inhibitors of Clostridium perfringens epsilon-toxin cytotoxicity using a cell-based high-throughput screen. Toxins (Basel) 2, 1825-1847.
106. Hirschberg H, Zhang MJ, Gach HM, Uzal FA, Peng Q, Sun CH, Chighvinadze D, &, Madsen SJ, (2009) Targeted delivery of bleomycin to the brain using photo-chemical internalization of Clostridium perfringens epsilon prototoxin. J Neurooncol 95, 317-329.